Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.
about
Reduced-Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients.Donor lymphocyte infusion and methotrexate for immune recovery after T-cell depleted haploidentical transplantation.Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.
P2860
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Nonmyeloablative Haploidentica ...... Risk Hematologic Malignancies.
@en
Nonmyeloablative Haploidentica ...... Risk Hematologic Malignancies.
@nl
type
label
Nonmyeloablative Haploidentica ...... Risk Hematologic Malignancies.
@en
Nonmyeloablative Haploidentica ...... Risk Hematologic Malignancies.
@nl
prefLabel
Nonmyeloablative Haploidentica ...... Risk Hematologic Malignancies.
@en
Nonmyeloablative Haploidentica ...... Risk Hematologic Malignancies.
@nl
P2093
P2860
P1476
Nonmyeloablative Haploidentica ...... -Risk Hematologic Malignancies
@en
P2093
Allen R Chen
David Loeb
Elias Zambidis
Ephraim J Fuchs
Heather J Symons
Javier Bolaños-Meade
Jessica Buddenbaum
Kenneth R Cooke
Leo Luznik
Mary Jo Holuba
P2860
P304
P356
10.1016/J.BBMT.2016.11.016
P577
2016-11-22T00:00:00Z